Coloplast A/s Stock News

Danish medical equipment maker Coloplast has agreed to buy Iceland-based biologic wound care firm Kerecis for up to $1.3 billion, it said on Friday.

Coloplast has signed an agreement to acquire Kerecis, an innovative, fast-growing company in the biologics wound care segment, for up to USD 1.3 billion (around DKK 8.9 billion), of which USD 1.2 bill

Coloplast A/S (OTCPK:CLPBF) Q1 2023 Earnings Conference Call February 3, 2023 5:00 AM ET Company Participants Kristian Villumsen - President and CEO Anders Lonning-Skovgaard - CFO Conference Call Part

Coloplast A/S (OTCPK:CLPBF) Q3 2022 Earnings Conference Call August 17, 2022 9:00 AM ET CompanyParticipants Kristian Villumsen - President & CEO Anders Lonning-Skovgaard - EVP & CFO Conference Call Pa

A list of companies covering some of the world's strongest economies in Scandinavia. Diversification can take place not only across sectors but also across geographies, with opportunities here across

The Intermittent Catheters Market 2022 report covers the whole scenario of the global market including key players, their future promotions, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics

Dublin, Jan. 31, 2022 (GLOBE NEWSWIRE) -- The "Urinary Incontinence Market by Product, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com''s offering. The global urinary incontinence market was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030. The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively. People undergoing urinary incontinence suffer from urine leakage that cannot be controlled. Patients suffering from severe urinary incontinence are recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC).

DUBLIN , Jan. 25, 2022 /PRNewswire/ -- The "Urinary Incontinence Market by Product, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com''s offering. The global urinary incontinence market was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030. The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively. People undergoing urinary incontinence suffer from urine leakage that cannot be controlled. Patients suffering from severe urinary incontinence are recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC).

CMI Research has released the latest version of its survey report on the Kidney Stone Management Devices Market, which includes 100+ market data tables, a pie chart, graphs and figures scattered over pages. The market is currently expanding its footprint.

The Wound Debridement Market research report provides an in-depth assessment of the current and future industry prospects with detailed market insights and changing market scenarios. In addition, the research report offers strategic research methodologies that help readers to make robust

CMI Research has released the latest version of its survey report on the Ostomy Care Market, which includes 100+ market data tables, a pie chart, graphs and figures scattered over pages. The market is currently expanding its footprint. The research

Coloplast A/S (OTCMKTS:CLPBY) was the target of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 13,000 shares, a decrease of 51.5% from the November 15th total of 26,800 shares. Based on an average daily volume of 101,500 shares, the days-to-cover ratio is presently 0.1 days. OTCMKTS:CLPBY []

Coloplast A/S (OTCMKTS:CLPBY) has received a consensus recommendation of Hold from the nine analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have given a buy recommendation to the company. The average 1-year target price among brokerages []

Coloplast A/S (OTCMKTS:CLPBF) dropped 2.6% on Friday . The stock traded as low as $158.59 and last traded at $158.59. Approximately 21 shares were traded during trading, a decline of 98% from the average daily volume of 855 shares. The stock had previously closed at $162.75. The company has a 50-day moving average of $165.16 []